Aurinia Pharmaceuticals Q1 EPS $0.16 Beats $0.10 Estimate, Sales $62.47M Beat $61.54M Estimate

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.10 by 60 percent. This is a 328.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $62.47 million which beat the analyst consensus estimate of $61.54 million by 1.51 percent. This is a 24.18 percent increase over sales of $50.30 million the same period last year.